Cargando…
Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
BACKGROUND: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) is a prevalent problem in patients with chronic kidney disease. It is associated with increased morbidity and mortality in patients who undergo dialysis. A significant proportion of patients do not respond to iron supplementa...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723725/ https://www.ncbi.nlm.nih.gov/pubmed/33344604 http://dx.doi.org/10.12998/wjcc.v8.i23.6048 |